76 results
Page 4 of 4
F-10/A
zdfvf0ja
16 Oct 15
Registration of securities (Canada) (amended)
12:00am
6-K
EX-99.1
r5ehyit
9 Feb 15
Aurinia Pharmaceuticals to Initiate an Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers
12:00am
6-K
EX-99.3
9xxzdh0q6 ai
15 Aug 14
Aurinia Reports Second Quarter 2014 Financial Results
12:00am
40FR12B/A
EX-99.27
pc7qnlju
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.15
izajlyh1b7gzm8fi49
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.26
8j6y0a dfsd
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.29
e0nt7q z0qf6
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.42
8ar9uflj5pj3q
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.25
77vab7j5vgs2gqt5
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.28
tqk7i9p9f9c1v50bb
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.16
r3r419z b9z4fso7mv
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.36
kk1ef4pgz2hml8 yp
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.24
7vh6zs2il up3
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.37
lu70cfwckp0ra13l
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B
EX-99.1
w9iyr6jeq
16 Apr 14
Initial registration of securities (Canada)
12:00am
40FR12B
EX-99.2
2clp5s fi
16 Apr 14
Initial registration of securities (Canada)
12:00am